Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer

Summary

The investigators do the clinical trial (patients with metastatic colorectal cancer treated with donafenib after failure of standard therapy) to assess safety and efficacy of donafenib in patients with metastatic colorectal cancer, progressing after all approved standard therapies.

Timeline

Start

2014-03

Primary completion

2015-10

Completion

2015-12

Drugs

Indications